Biotricity Stock Current Asset
| BTCY Stock | USD 1.20 0.05 4.00% |
Biotricity fundamentals help investors to digest information that contributes to Biotricity's financial success or failures. It also enables traders to predict the movement of Biotricity Stock. The fundamental analysis module provides a way to measure Biotricity's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Biotricity stock.
At this time, Biotricity's Non Current Assets Total are fairly stable compared to the past year. Other Current Assets is likely to rise to about 710.7 K in 2024, whereas Total Current Assets are likely to drop slightly above 3.2 M in 2024. Biotricity | Current Asset |
Biotricity Company Current Asset Analysis
Biotricity's Current Asset is all of the company's assets that can be used to pay off current liabilities within the current fiscal period or over the next 12 months. Current Asset includes cash or cash equivalents, accounts receivable, short-term investments, and the portion of prepaid liabilities which will be paid within the next 12 months. Because these assets are easily turned into cash, they are sometimes referred to as liquid assets.
Current Biotricity Current Asset | 11 K |
Most of Biotricity's fundamental indicators, such as Current Asset, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Biotricity is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Biotricity Current Asset Historical Pattern
Today, most investors in Biotricity Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Biotricity's growth ratios. Consistent increases or drops in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's current asset growth rates may not be enough to decide which company is a better investment. That's why investors frequently use a static breakdown of Biotricity current asset as a starting point in their analysis.
Biotricity Current Asset |
| Timeline |
Current Asset is important to company's creditors and private equity firms as they will often be interested in how much that company has in current assets since these assets can be easily liquidated in case the company goes bankrupt. However, it is usually not enough to know if a company is in good shape just based on current asset alone; the amount of current liabilities should always be considered.
| Competition |
Biotricity Total Assets
Total Assets |
|
In accordance with the recently published financial statements, Biotricity has a Current Asset of 11 K. This is 100.0% lower than that of the Health Care Equipment & Supplies sector and 100.0% lower than that of the Health Care industry. The current asset for all United States stocks is 100.0% higher than that of the company.
Biotricity Current Valuation Drivers
We derive many important indicators used in calculating different scores of Biotricity from analyzing Biotricity's financial statements. These drivers represent accounts that assess Biotricity's ability to generate profits relative to its revenue, operating costs, and shareholders' equity. Below are some of Biotricity's important valuation drivers and their relationship over time.
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Market Cap | 5.1M | 5.8M | 15.0M | 17.2M | 4.0M | 11.8M | |
| Enterprise Value | 5.9M | 7.2M | 17.5M | 20.5M | 23.0M | 11.4M |
Biotricity Fundamentals
| Return On Equity | -41.01 | ||||
| Return On Asset | -0.95 | ||||
| Profit Margin | (1.25) % | ||||
| Operating Margin | (0.43) % | ||||
| Current Valuation | 35.75 M | ||||
| Shares Outstanding | 9.31 M | ||||
| Shares Owned By Insiders | 14.81 % | ||||
| Shares Owned By Institutions | 4.78 % | ||||
| Number Of Shares Shorted | 443.36 K | ||||
| Price To Earning | (6.70) X | ||||
| Price To Book | 33.02 X | ||||
| Price To Sales | 0.94 X | ||||
| Revenue | 9.64 M | ||||
| Gross Profit | 4.57 M | ||||
| EBITDA | (15.59 M) | ||||
| Net Income | (18.66 M) | ||||
| Cash And Equivalents | 2.89 M | ||||
| Cash Per Share | 0.05 X | ||||
| Total Debt | 19.55 M | ||||
| Debt To Equity | 6.45 % | ||||
| Current Ratio | 1.54 X | ||||
| Book Value Per Share | (2.95) X | ||||
| Cash Flow From Operations | (13.55 M) | ||||
| Short Ratio | 4.94 X | ||||
| Earnings Per Share | (1.75) X | ||||
| Target Price | 4.0 | ||||
| Number Of Employees | 55 | ||||
| Beta | 1.54 | ||||
| Market Capitalization | 11.6 M | ||||
| Total Asset | 6.51 M | ||||
| Retained Earnings | (112.57 M) | ||||
| Working Capital | (6.44 M) | ||||
| Current Asset | 11 K | ||||
| Current Liabilities | 303 K | ||||
| Net Asset | 6.51 M |
About Biotricity Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Biotricity's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Biotricity using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Biotricity based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Biotricity in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Biotricity's short interest history, or implied volatility extrapolated from Biotricity options trading.
Pair Trading with Biotricity
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Biotricity position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Biotricity will appreciate offsetting losses from the drop in the long position's value.Moving together with Biotricity Stock
| 0.76 | CI | Cigna Corp | PairCorr |
| 0.75 | ELMD | Electromed | PairCorr |
Moving against Biotricity Stock
| 0.73 | LUNG | PulmonxCorp | PairCorr |
| 0.72 | ALHC | Alignment Healthcare LLC Trending | PairCorr |
| 0.72 | AXGN | Axogen Inc Financial Report 14th of May 2024 | PairCorr |
| 0.72 | TMCI | Treace Medical Concepts Financial Report 13th of May 2024 | PairCorr |
| 0.68 | GH | Guardant Health Financial Report 14th of May 2024 | PairCorr |
The ability to find closely correlated positions to Biotricity could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Biotricity when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Biotricity - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Biotricity to buy it.
The correlation of Biotricity is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Biotricity moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Biotricity moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Biotricity can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Biotricity Piotroski F Score and Biotricity Altman Z Score analysis. For more information on how to buy Biotricity Stock please use our How to Invest in Biotricity guide.Note that the Biotricity information on this page should be used as a complementary analysis to other Biotricity's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Investing Opportunities module to build portfolios using our predefined set of ideas and optimize them against your investing preferences.
Complementary Tools for Biotricity Stock analysis
When running Biotricity's price analysis, check to measure Biotricity's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Biotricity is operating at the current time. Most of Biotricity's value examination focuses on studying past and present price action to predict the probability of Biotricity's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Biotricity's price. Additionally, you may evaluate how the addition of Biotricity to your portfolios can decrease your overall portfolio volatility.
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Transaction History View history of all your transactions and understand their impact on performance | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. |
Is Biotricity's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Biotricity. If investors know Biotricity will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Biotricity listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.75) | Revenue Per Share 1.319 | Quarterly Revenue Growth 0.209 | Return On Assets (0.95) | Return On Equity (41.01) |
The market value of Biotricity is measured differently than its book value, which is the value of Biotricity that is recorded on the company's balance sheet. Investors also form their own opinion of Biotricity's value that differs from its market value or its book value, called intrinsic value, which is Biotricity's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Biotricity's market value can be influenced by many factors that don't directly affect Biotricity's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Biotricity's value and its price as these two are different measures arrived at by different means. Investors typically determine if Biotricity is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Biotricity's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.